COSCIENS Biopharma Inc. (CSCI)

COSCIENS Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	20	34.02	50.61	65.3	24.27	7.84
Cash & Short-Term Investments	20	34.02	50.61	65.3	24.27	7.84
Cash Growth	-48.40%	-32.79%	-22.49%	169.05%	209.66%	-45.99%
Accounts Receivable	1.89	0.07	0.4	0.88	1.19	0.21
Other Receivables	0.12	0.28	1.76	2.8	1.09	0.45
Receivables	2.02	0.34	2.16	3.68	2.28	0.66
Inventory	3.31	0.07	0.23	0.07	0.02	1.38
Prepaid Expenses	1.95	0.25	0.43	0.42	1.02	0.79
Other Current Assets	0.96	1.69	2.06	1.35	0.02	0.25
Total Current Assets	28.22	36.37	55.49	70.82	27.61	10.91
Property, Plant & Equipment	11.81	0.32	0.22	0.19	0.18	0.62
Goodwill	-	-	-	8.13	8.82	8.05
Other Intangible Assets	1.81	-	-	0.63	0.06	0.04
Long-Term Deferred Tax Assets	1.08	-	-	-	-	-
Other Long-Term Assets	0.86	0.33	0.32	0.34	0.34	0.36
Total Assets	43.77	37.02	56.03	80.1	37.01	19.98
Accounts Payable	2.4	1.87	2.04	0.93	1.19	1.09
Accrued Expenses	2.56	1.76	1.79	1.74	1.01	1.06
Short-Term Debt	-	-	-	-	-	0
Current Portion of Leases	0.41	0.16	0.11	0.13	0.14	0.65
Current Income Taxes Payable	0.11	0.11	0.11	0.12	0.12	1.45
Current Unearned Revenue	0.05	0.22	2.95	4.82	2.19	0.99
Other Current Liabilities	2.65	0.43	0.05	0.03	0.09	0.42
Total Current Liabilities	8.17	4.54	7.04	7.77	4.74	5.66
Long-Term Leases	1.21	0.12	0.07	0.03	0.05	0.26
Long-Term Unearned Revenue	1.92	1.54	1.79	1.59	3.29	0.19
Other Long-Term Liabilities	-	-	0.19	0.24	0.28	2.56
Total Liabilities	23.76	18.82	20.25	27.12	23.79	22.44
Common Stock	22.39	293.41	293.41	293.41	235.01	224.53
Additional Paid-In Capital	-	90.71	90.33	-	-	-
Retained Earnings	-5.16	-369.83	-352.08	-334.62	-322.66	-316.89
Comprehensive Income & Other	2.78	3.91	4.12	94.2	100.86	89.9
Shareholders' Equity	20.01	18.2	35.78	52.99	13.21	-2.46
Total Liabilities & Equity	43.77	37.02	56.03	80.1	37.01	19.98
Total Debt	1.62	0.28	0.18	0.16	0.18	0.91
Net Cash (Debt)	18.38	33.74	50.43	65.14	24.09	6.93
Net Cash Growth	-52.30%	-33.10%	-22.58%	170.43%	247.53%	-49.68%
Net Cash Per Share	11.31	27.79	41.54	56.68	58.63	39.62
Filing Date Shares Outstanding	3.12	1.21	1.21	1.21	1.21	0.23
Total Common Shares Outstanding	3.12	1.21	1.21	1.21	0.63	0.2
Working Capital	20.05	31.83	48.44	63.05	22.87	5.25
Book Value Per Share	6.41	14.99	29.47	43.65	21.08	-12.32
Tangible Book Value	18.21	18.2	35.78	44.23	4.34	-10.55
Tangible Book Value Per Share	5.83	14.99	29.47	36.44	6.92	-52.78
Machinery	13.16	0.49	0.45	0.47	0.55	0.74
Leasehold Improvements	6.57	-	-	-	-	0.03

Source: S&P Capital IQ. Standard template. Financial Sources.